Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradicationHarry L.A. Janssen, Jordan J. Feld, Harald Hofer et al.|Journal of Hepatology|2016Cited by 273
Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII StudyChristopher Payan, Bruno Fouqueray, F Roudot-Thoraval et al.|Journal of Viral Hepatitis|2005Cited by 143
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysisVíctor Sapena, María Reig, Marco Enea et al.|Gut|2021Cited by 96
Bystander hyperactivation of preimmune CD8+ T cells in chronic HCV patientsCécile Alanio, Matthew L. Albert, Francesco Nicoli et al.|eLife|2015Cited by 56
66 SILEN-C2: SUSTAINED VIROLOGIC RESPONSE (SVR) AND SAFETY OF BI201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (P/R) IN CHRONIC HCV GENOTYPE-1 PATIENTS WITH NON-RESPONSE TO P/RMark Sulkowski, Gerhard Steinmann, Yakov Datsenko et al.|Journal of Hepatology|2011Cited by 30